Stay updated on LN-145 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the LN-145 in Solid Tumors Clinical Trial page.
Latest updates to the LN-145 in Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedAdded a Locations section showing Texas (Houston, TX) as a study site. Updated the page to revision v3.3.3; removed the old Texas Locations label and the HHS Vulnerability Disclosure link.SummaryDifference0.2%
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedPage metadata updated to revision 3.3.2 and Last Update Posted (Estimated) timestamps. The core study content and eligibility criteria remain unchanged.SummaryDifference0.2%
- Check41 days agoChange DetectedRemoved the government funding status notice about potential delays and outdated information, which previously directed users to cc.nih.gov for operating status and opm.gov for updates.SummaryDifference0.3%
- Check56 days agoChange DetectedNo substantive changes detected between the two page screenshots; core sections such as Brief Summary, Objectives, Eligibility Criteria, Endpoints, and Contacts appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check84 days agoChange DetectedKey changes: added notice about funding-related site status and new topic “Bone osteosarcoma” with a new revision v3.2.0; removed the term “Thyroid gland undifferentiated (anaplastic) carcinoma” and the older revision v3.1.0.SummaryDifference2%
- Check91 days agoChange DetectedExpanded core content to include broader cancer, immunology, and musculoskeletal topics and updated the page version to v3.1.0; removed older, more specific terms and the older revision tag.SummaryDifference2%
Stay in the know with updates to LN-145 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LN-145 in Solid Tumors Clinical Trial page.